GLENMARK PHARMACEUTICALS Stock/ INE935A01035 /
07.05.2024 12:00:01 | Diff. -24,90 | Volumen | Geld07.05.2024 | Brief12:32:45 | Tageshoch | Tagestief |
---|---|---|---|---|---|---|
1.015,75INR | -2,39% | 560.484 Umsatz: 567,97 Mio. |
1.012,90Geld Vol: 450 | 1.015,75Brief Vol: 171 | 1.043,75 | 997,80 |
GlobeNewswire
20:53
ROSEN, SKILLED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Secure Counsel Befo...
GlobeNewswire
20:52
Lowey Dannenberg, P.C. is Investigating Banco Santander, S.A. (“Banco Santander”) (NYSE:SAN) for Pot...
GlobeNewswire
20:49
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ocugen, Inc. Investors to Secure Counsel Before Importan...
GlobeNewswire
20:35
Brookfield Reinsurance Announces Credit Rating Upgrade of American Equity Investment Life Insurance ...
GlobeNewswire
20:34
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Agains...
GlobeNewswire
20:27
Toll Brothers Honored at the Shore Builders Association of Central New Jersey Awards
GlobeNewswire
20:11
In Honor of Fentanyl Awareness Day, American Addiction Centers Highlights a Valuable Resource for Fa...
GlobeNewswire
20:06
COLLEGE FOR CREATIVE STUDIES FASHION DESIGN PROGRAM PRESENTS FOURTH ANNUAL RUNWAY FASHION SHOW
GlobeNewswire
19:52
Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire
19:42
NAR Chief Economist Lawrence Yun Predicts Falling Long-Term Interest Rates, Rising Existing-Home Sal...
GlobeNewswire
19:40
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Altimmune, Inc (AL...
- Erste Seite
- Zurück
- 1
- 2
- 3
- 4
- Weiter
- Letzte Seite